1,2-dimethylhydrazine has been researched along with capecitabine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dudhipala, N; Puchchakayala, G | 1 |
1 other study(ies) available for 1,2-dimethylhydrazine and capecitabine
| Article | Year |
|---|---|
Capecitabine lipid nanoparticles for anti-colon cancer activity in 1,2-dimethylhydrazine-induced colon cancer: preparation, cytotoxic, pharmacokinetic, and pathological evaluation.
Topics: 1,2-Dimethylhydrazine; Animals; Antineoplastic Agents; Capecitabine; Carcinogens; Cell Survival; Colonic Neoplasms; Cytotoxins; Drug Carriers; HT29 Cells; Humans; Lipids; Male; Nanoparticles; Rats; Rats, Wistar; X-Ray Diffraction | 2018 |